Oh AS - Search Results

1

Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.

Oh AS, Lahusen JT, Chien CD, Fereshteh MP, Zhang X, Dakshanamurthy S, Xu J, Kagan BL, Wellstein A, Riegel AT. Oh AS, et al. Mol Cell Biol. 2008 Nov;28(21):6580-93. doi: 10.1128/MCB.00118-08. Epub 2008 Sep 2. Mol Cell Biol. 2008. PMID: 18765637 Free PMC article.

2

The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.

Oh A, List HJ, Reiter R, Mani A, Zhang Y, Gehan E, Wellstein A, Riegel AT. Oh A, et al. Cancer Res. 2004 Nov 15;64(22):8299-308. doi: 10.1158/0008-5472.CAN-04-0354. Cancer Res. 2004. PMID: 15548698

3

Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.

Lahusen T, Fereshteh M, Oh A, Wellstein A, Riegel AT. Lahusen T, et al. Cancer Res. 2007 Aug 1;67(15):7256-65. doi: 10.1158/0008-5472.CAN-07-1013. Cancer Res. 2007. PMID: 17671194 Free PMC article.

4

Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.

Reiter R, Oh AS, Wellstein A, Riegel AT. Reiter R, et al. Among authors: oh as. Oncogene. 2004 Jan 15;23(2):403-9. doi: 10.1038/sj.onc.1207202. Oncogene. 2004. PMID: 14691461

5

E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.

Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL, Weissman AM, Schlegel R, Wellstein A, Riegel AT. Mani A, et al. Among authors: oh as. Cancer Res. 2006 Sep 1;66(17):8680-6. doi: 10.1158/0008-5472.CAN-06-0557. Cancer Res. 2006. PMID: 16951183

6

Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.

Chien CD, Kirilyuk A, Li JV, Zhang W, Lahusen T, Schmidt MO, Oh AS, Wellstein A, Riegel AT. Chien CD, et al. Among authors: oh as. J Biol Chem. 2011 Jul 29;286(30):26813-27. doi: 10.1074/jbc.M110.216200. Epub 2011 Jun 2. J Biol Chem. 2011. PMID: 21636853 Free PMC article.

7

Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.

Tilli MT, Reiter R, Oh AS, Henke RT, McDonnell K, Gallicano GI, Furth PA, Riegel AT. Tilli MT, et al. Among authors: oh as. Mol Endocrinol. 2005 Mar;19(3):644-56. doi: 10.1210/me.2004-0106. Epub 2004 Nov 18. Mol Endocrinol. 2005. PMID: 15550471

8

Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.

Oh AS, Lorant LA, Holloway JN, Miller DL, Kern FG, El-Ashry D. Oh AS, et al. Mol Endocrinol. 2001 Aug;15(8):1344-59. doi: 10.1210/mend.15.8.0678. Mol Endocrinol. 2001. PMID: 11463858

9

Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.

Ochnik AM, Peterson MS, Avdulov SV, Oh AS, Bitterman PB, Yee D. Ochnik AM, et al. Among authors: oh as. Neoplasia. 2016 Feb;18(2):100-10. doi: 10.1016/j.neo.2016.01.001. Neoplasia. 2016. PMID: 26936396 Free PMC article.

10

Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor.

Zeng X, Zhang H, Oh A, Zhang Y, Yee D. Zeng X, et al. Breast Cancer Res Treat. 2012 May;133(1):117-26. doi: 10.1007/s10549-011-1713-x. Epub 2011 Aug 18. Breast Cancer Res Treat. 2012. PMID: 21850397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters